CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2026
Detailed information
CancerLivER ID2026
Biomarker miR-455-3p
Biomarker Name/Symbol (given in Publication)miR-455-3p
BiomoleculemiRNA
SubjectSprague- Dawley rats
Degree of ValidityTAA-induced hepatocarcinogenesis
Experimental ConditionControl Sprague-Dawley rats and rats treated with TAA at three doses; can predict early HCC
Cancer typeTAA-induced liver carcinogenesis.
RegulationDownregulated in TAA-induced hepatocarcinogenesis
Level of significance p < 0.05
SourceTissue
PMID28596526
Type of BiomarkerPotential Diagnostic and Prognostic *
Pathwayp53-, TGF-β-, MAPK- and Wnt-signaling
Cohort48 samples
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseTAA-induced liver carcinogenesis.
Year of Publication2017
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top